[Cl:1][CH2:2][CH2:3][NH:4][C:5](=[O:12])[C:6]1[CH:11]=[CH:10][CH:9]=[CH:8][CH:7]=1.[CH3:13][N:14]1[C:19]([N:20]2[CH2:25][CH2:24][NH:23][CH2:22][CH2:21]2)=[CH:18][C:17](=[O:26])[N:16]([CH3:27])[C:15]1=[O:28].[I-].[Na+].C(N(CC)CC)C>O1CCOCC1>[ClH:1].[CH3:13][N:14]1[C:19]([N:20]2[CH2:25][CH2:24][N:23]([CH2:2][CH2:3][NH:4][C:5](=[O:12])[C:6]3[CH:11]=[CH:10][CH:9]=[CH:8][CH:7]=3)[CH2:22][CH2:21]2)=[CH:18][C:17](=[O:26])[N:16]([CH3:27])[C:15]1=[O:28]In 20 ml of dioxane were suspended 2.76 g of N-(2-chloroethyl)benzamide, 1.12 g of 1,3-dimethyl-6-(1-piperazinyl)-2,4(1H,3H)-pyrimidinedione, 3.75 g of sodium iodide and 1.4 ml of triethylamine, and the solution was heated under reflux with stirring for 15 hours. Afterward, the solvent was distilled off, and the resultant residue was dissolved in chloroform, washed with water, and then concentrated to dryness. The residue was purified through a silica gel column chromatograph (chloroform/methanol=100/1 to 100/5 in volume ratio), thereby obtaining 1.25 g of the crystals of 1,3-dimethyl-6-[4-(N-benzoyl-2-aminoethyl)piperazin-1-yl]-2,4(1H,3H)-pyrimidinedione.